ActiTrexx GmbH | Finanzwire

Basculer en Français

10884	Companies
236852	Keywords
165739	Articles
127076	Press releases

Home
Companies
ActiTrexx GmbH

BRIEF

published on 10/20/2025 at 10:05, 10 months 6 days ago

ActiTrexx Completes Final Patient Treatment in GvHD Therapy Study

Clinical Study Graft-versus-Host Disease Actileucel Immune Therapy Regulatory T Cells
PRESS RELEASE

published on 10/20/2025 at 10:00, 10 months 6 days ago

ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention

ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel Phase Ib/II Study
BRIEF

published on 03/19/2024 at 10:05, 2 years 5 months ago

ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy

Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
PRESS RELEASE

published on 03/19/2024 at 10:00, 2 years 5 months ago

ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment

Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study

Accesswire

Published on 08/26/2026 at 15:00, 19 minutes ago

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 08/26/2026 at 15:00, 19 minutes ago

Arcus Announces Voting Results of the Annual General and Special Meeting
Published on 08/26/2026 at 14:30, 49 minutes ago

Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update
Published on 08/26/2026 at 14:30, 49 minutes ago

NV Gold Announces Commencement of 2026 Drill Program at its Slumber Gold Project
Published on 08/26/2026 at 14:17, 1 hour 2 minutes ago

Worksport (NASDAQ: WKSP) Posts Record $2.5M July Orders; Seven-Month Consecutive Sales Climb Continues; $30M ARR

View all ACCESSWIRE

EQS Group

Published on 08/26/2026 at 15:07, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/26/2026 at 15:07, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 08/26/2026 at 15:06, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 08/26/2026 at 15:05, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Rotork plc
Published on 08/26/2026 at 15:05, 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

Les Echos

Published on 08/25/2026 at 17:45, 21 hours 34 minutes ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 21 hours 34 minutes ago

Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
Published on 08/25/2026 at 08:30, 1 day 6 hours ago

Eiffage wins several contracts worth a total of €132 million in the healthcare sector
Published on 08/24/2026 at 18:00, 1 day 21 hours ago

Outstanding shares and voting rights statement at 31 July 2026
Published on 08/24/2026 at 17:59, 1 day 21 hours ago

Saint-Gobain strengthens its positioning in construction chemicals and light construction in Latin America

View all LES ECHOS COMFI WIRE